Optimal Remifentanil Dosage for Intubation without Muscle Relaxants in Elderly Patients

被引:19
作者
Goo, Eui-Kyoung [1 ]
Oh, Ah-Young [1 ]
Cho, Suk-Ju [2 ]
Seo, Kwang-Suk [3 ]
Jeon, Young-Tae [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Anesthesiol & Pain Med, Gyeonggi Do 463707, Seongnam Si, South Korea
[2] Jeju Natl Univ Hosp, Dept Anesthesiol & Pain Med, Cheju, South Korea
[3] Seoul Natl Univ, Sch Dent, Dept Dent Anesthesiol, Seoul, South Korea
关键词
NEUROMUSCULAR BLOCKING-AGENTS; TRACHEAL INTUBATION; MUSCULAR RELAXATION; PROPOFOL; PHARMACODYNAMICS;
D O I
10.1007/s40266-012-0019-y
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Remifentanil used in combination with propofol provides adequate conditions for tracheal intubation without muscle relaxants. Delivery of the optimal dose is important to prevent poor intubation conditions and drug-related complications. No previous study has investigated the use of a remifentanil propofol combination in elderly patients. Objective The aim of the present study was to determine the dose of remifentanil necessary for rapid tracheal intubation without the use of muscle relaxants in elderly patients. Methods A total of 24 patients >65 years of age with American Society of Anesthesiologists status I-II who were scheduled to undergo elective surgery under general anaesthesia were enrolled. After premedication with glycopyrrolate and midazolam, anaesthesia was induced with 1 mg/kg propofol, and a blinded dose of remifentanil was then infused over 30 s after confirming the patient's loss of consciousness. The remifentanil dose was determined using Dixon's up-and-down method, starting at 2 mu g/kg. Intubation was performed 60 s after the loss of consciousness. Intubation conditions were assessed with the Stockholm score and an assessment of excellent or good condition was regarded as being clinically acceptable. The effective dose needed for acceptable intubation conditions in 50 % of the subjects (ED50) was determined by Dixon's up-and-down method, and the ED50 and the effective dose needed for acceptable intubation conditions in 95 % of the subjects (ED95) with 95 % confidence intervals (CIs) were determined by probit analysis. Results In total, 24 patients were recruited and the median age (interquartile range) was 70 (66-74) years. The ED50 of remifentanil for tracheal intubation was 1.15 (standard deviation 0.13) mu g/kg. The ED50 and ED95 of remifentanil obtained from the probit analyses were 1.16 (95 % CI 1.01, 1.29) mu g/kg and 1.39 (95 % CI 1.27, 2.13) mu g/kg, respectively. Blood pressure and heart rate decreased significantly after propofol and remifentanil administration, but were within 30 % of baseline values. Conclusions Combined with 1 mg/kg propofol, 1.39 (95 % CI 1.27, 2.13) mu g/kg remifentanil resulted in acceptable intubation conditions within 60 s in 95 % of elderly patients without major complications.
引用
收藏
页码:905 / 909
页数:5
相关论文
共 16 条
[1]   Tracheal intubation in routine practice with and without muscular relaxation: an observational study [J].
Baillard, C ;
Adnet, F ;
Borron, SW ;
Racine, SX ;
Kaci, FA ;
Fournier, JL ;
Larmignat, R ;
Cupa, M ;
Baillard, C .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2005, 22 (09) :672-677
[2]   Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol [J].
Bouvet, L. ;
Stoian, A. ;
Rimmele, T. ;
Allaouchiche, B. ;
Chassard, D. ;
Boselli, E. .
ANAESTHESIA, 2009, 64 (07) :719-726
[3]  
Bouvet L, 2008, CAN J ANAESTH, V55, P674, DOI 10.1007/BF03017743
[4]   Comparison of two induction regimens using or not using muscle relaxant: Impact on postoperative upper airway discomfort [J].
Combes, X. ;
Andriamifady, L. ;
Dufresne, E. ;
Suen, P. ;
Sauvat, S. ;
Scherrer, E. ;
Feiss, P. ;
Martyr, J. ;
Duvaldestin, P. .
BRITISH JOURNAL OF ANAESTHESIA, 2007, 99 (02) :276-281
[5]   STAIRCASE BIOASSAY - THE UP-AND-DOWN METHOD [J].
DIXON, WJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1991, 15 (01) :47-50
[6]   Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision [J].
Fuchs-Buder, T. ;
Claudius, C. ;
Skovgaard, L. T. ;
Eriksson, L. I. ;
Mirakhur, R. K. ;
Viby-Mogensen, J. .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2007, 51 (07) :789-808
[7]   Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation [J].
Hall, AP ;
Thompson, JP ;
Leslie, NAP ;
Fox, AJ ;
Kumar, N ;
Rowbotham, DJ .
BRITISH JOURNAL OF ANAESTHESIA, 2000, 84 (01) :100-102
[8]   Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol [J].
Klemola, UM ;
Mennander, S ;
Saarnivaara, L .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (04) :465-469
[9]   THE EFFECTS OF THIOPENTONE AND PROPOFOL ON UPPER AIRWAY INTEGRITY [J].
MCKEATING, K ;
BALI, IM ;
DUNDEE, JW .
ANAESTHESIA, 1988, 43 (08) :638-640
[10]   Comparison of intubating conditions following propofol and succinylcholine with propofol and remifentanil 2 μg kg-1 or 4 μg kg-1 [J].
McNeil, IA ;
Culbert, B ;
Russell, I .
BRITISH JOURNAL OF ANAESTHESIA, 2000, 85 (04) :623-625